Probiotics in Critically Ill Patients: An Umbrella Review

Overview

Journal Indian J Crit Care Med

Specialty Critical Care

Date 2022 May 6

PMID 35519905

Authors

Amirreza Naseri

Sepideh Seyedi-Sahebari

Ata Mahmoodpoor

Sarvin Sanaie

Affiliations

Soon will be listed here.

Abstract

Objectives: Probiotics are live microorganisms which when administered in adequate amounts confer a health benefit on the host. Because of the wide usage of antibiotics, acute changes in diet, and the stress of illness, critically ill patients' homeostasis of the gut microbiome can be disrupted during intensive care unit (ICU) confinement; probiotics are suggested as a beneficial intervention in critically ill patients. We tried to give an overview of the effects of probiotic supplements in critically ill patients based on published systematic reviews (SRs) and meta-analyses (MAs).

Data Sources: A systematic search was performed in four databases as well as hand searching.

Study Selection: The results were independently screened in two title/abstracts and full-text stages.

Data Extraction: Any reported outcomes in each study were extracted, using a data extraction table.

Data Synthesis: A wide range of outcomes of using probiotic supplements in critically ill patients have been reported in 20 included studies. Based on the current knowledge, we can say that probiotics may reduce the rate of ventilator-associated pneumonia, nosocomial pneumonia, the overall infection rate, duration of mechanical ventilation, and antibiotic use in critically ill patients, but there is not a significant association between using the probiotics and mortality, length of hospitalization, and incidence of diarrhea.

Conclusion: Despite the various beneficial effects of probiotics in critically ill patients, there is not yet much evidence supporting the routine use of these supplements and further well-designed multicenter trials are needed to provide "evidence-based" recommendations.

How To Cite This Article: Naseri A, Seyedi-Sahebari S, Mahmoodpoor A, Sanaie S. Probiotics in Critically Ill Patients: An Umbrella Review. Indian J Crit Care Med 2022;26(3):339-360.

Citing Articles

Accounting for the health risk of probiotics.

Liu X, Zhao H, Wong A Heliyon. 2024; 10(6):e27908.

PMID: 38510031 PMC: 10950733. DOI: 10.1016/j.heliyon.2024.e27908.

Optimization of Therapy and the Risk of Probiotic Use during Antibiotherapy in Septic Critically Ill Patients: A Narrative Review.

Onofrei M, Ghiciuc C, Luca C, Postolache P, Sapaniuc C, Enache Leonte G Medicina (Kaunas). 2023; 59(3).

PMID: 36984479 PMC: 10056847. DOI: 10.3390/medicina59030478.

Gut Microbiota Modulation and Prevention of Dysbiosis as an Alternative Approach to Antimicrobial Resistance: A Narrative Review.

Matzaras R, Nikopoulou A, Protonotariou E, Christaki E Yale J Biol Med. 2022; 95(4):479-494.

PMID: 36568836 PMC: 9765331.

Probiotics: Should We Use Them Proactively in Critical Illness?.

Soni K Indian J Crit Care Med. 2022; 26(3):266-267.

PMID: 35519925 PMC: 9015945. DOI: 10.5005/jp-journals-10071-24174.

References

Manzanares W, Langlois P, Wischmeyer P . Restoring the Microbiome in Critically Ill Patients: Are Probiotics Our True Friends When We Are Seriously Ill?. JPEN J Parenter Enteral Nutr. 2017; 41(4):530-533. DOI: 10.1177/0148607117700572. View

McFarland L, Evans C, Goldstein E . Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2018; 5:124. PMC: 5949321. DOI: 10.3389/fmed.2018.00124. View

Melsen W, Rovers M, Bonten M . Ventilator-associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med. 2009; 37(10):2709-18. DOI: 10.1097/ccm.0b013e3181ab8655. View

Doron S, Snydman D . Risk and safety of probiotics. Clin Infect Dis. 2015; 60 Suppl 2:S129-34. PMC: 4490230. DOI: 10.1093/cid/civ085. View

Morrow L, Wischmeyer P . Blurred Lines: Dysbiosis and Probiotics in the ICU. Chest. 2016; 151(2):492-499. DOI: 10.1016/j.chest.2016.10.006. View

McClave S, Taylor B, Martindale R, Warren M, Johnson D, Braunschweig C . Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016; 40(2):159-211. DOI: 10.1177/0148607115621863. View

Roquilly A, Marret E, Abraham E, Asehnoune K . Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis. Clin Infect Dis. 2014; 60(1):64-75. DOI: 10.1093/cid/ciu740. View

Whelan K, Myers C . Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr. 2010; 91(3):687-703. DOI: 10.3945/ajcn.2009.28759. View

Doron S, Hibberd P, Gorbach S . Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol. 2008; 42 Suppl 2:S58-63. DOI: 10.1097/MCG.0b013e3181618ab7. View

10.

Arthur L, Kizor R, Selim A, Van Driel M, Seoane L . Antibiotics for ventilator-associated pneumonia. Cochrane Database Syst Rev. 2016; 10:CD004267. PMC: 6461148. DOI: 10.1002/14651858.CD004267.pub4. View

11.

Santacroce L, Charitos I, Bottalico L . A successful history: probiotics and their potential as antimicrobials. Expert Rev Anti Infect Ther. 2019; 17(8):635-645. DOI: 10.1080/14787210.2019.1645597. View

12.

Hempel S, Newberry S, Ruelaz A, Wang Z, Miles J, Suttorp M . Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess (Full Rep). 2012; (200):1-645. PMC: 4780970. View

13.

Gu W, Deng T, Gong Y, Jing R, Liu J . The effects of probiotics in early enteral nutrition on the outcomes of trauma: a meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr. 2012; 37(3):310-7. DOI: 10.1177/0148607112463245. View

14.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

15.

Brenner L, Stearns-Yoder K, Hoffberg A, Penzenik M, Starosta A, Hernandez T . Growing literature but limited evidence: A systematic review regarding prebiotic and probiotic interventions for those with traumatic brain injury and/or posttraumatic stress disorder. Brain Behav Immun. 2017; 65:57-67. DOI: 10.1016/j.bbi.2017.06.003. View

16.

Szanto M, Dozsa A, Antal D, Szabo K, Kemeny L, Bai P . Targeting the gut-skin axis-Probiotics as new tools for skin disorder management?. Exp Dermatol. 2019; 28(11):1210-1218. DOI: 10.1111/exd.14016. View

17.

Barraud D, Bollaert P, Gibot S . Impact of the administration of probiotics on mortality in critically ill adult patients: a meta-analysis of randomized controlled trials. Chest. 2013; 143(3):646-655. DOI: 10.1378/chest.12-1745. View

18.

Elke G, Hartl W, Kreymann K, Adolph M, Felbinger T, Graf T . Clinical Nutrition in Critical Care Medicine - Guideline of the German Society for Nutritional Medicine (DGEM). Clin Nutr ESPEN. 2019; 33:220-275. DOI: 10.1016/j.clnesp.2019.05.002. View

19.

van Ruissen M, Bos L, Dickson R, Dondorp A, Schultsz C, Schultz M . Manipulation of the microbiome in critical illness-probiotics as a preventive measure against ventilator-associated pneumonia. Intensive Care Med Exp. 2019; 7(Suppl 1):37. PMC: 6658628. DOI: 10.1186/s40635-019-0238-1. View

20.

Branch-Elliman W, Wright S, Howell M . Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis. Am J Respir Crit Care Med. 2015; 192(1):57-63. DOI: 10.1164/rccm.201412-2316OC. View